TrialHeadache2022

A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene-related peptide ligand (galcanezumab) or receptor (erenumab) antagonist.

David Kudrow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.